As of 2026-01-27, the Relative Valuation of Medexus Pharmaceuticals Inc (MDP.TO) is 1.10 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 2.93 CAD, the upside of Medexus Pharmaceuticals Inc based on Relative Valuation is -62.4%.
The range of the Relative Valuation is 0.29 - 2.08 CAD.
| Range | Selected | |
| Trailing P/E multiples | 24.4x - 72.7x | 28.6x |
| Forward P/E multiples | 20.9x - 24.7x | 22.2x |
| Fair Price | 0.29 - 2.08 | 1.10 |
| Upside | -90.2% - -29.0% | -62.4% |
| Date | P/E |
| 2026-01-23 | 244.21 |
| 2026-01-22 | 241.66 |
| 2026-01-21 | 239.96 |
| 2026-01-20 | 238.26 |
| 2026-01-19 | 241.66 |
| 2026-01-16 | 239.11 |
| 2026-01-15 | 234.00 |
| 2026-01-14 | 242.51 |
| 2026-01-13 | 245.92 |
| 2026-01-12 | 251.02 |
| 2026-01-09 | 245.06 |
| 2026-01-08 | 255.28 |
| 2026-01-07 | 245.92 |
| 2026-01-06 | 253.57 |
| 2026-01-05 | 252.72 |
| 2026-01-02 | 262.93 |
| 2025-12-31 | 247.62 |
| 2025-12-30 | 251.02 |
| 2025-12-29 | 252.72 |
| 2025-12-24 | 235.70 |
| 2025-12-23 | 237.41 |
| 2025-12-22 | 233.15 |
| 2025-12-19 | 226.34 |
| 2025-12-18 | 226.34 |
| 2025-12-17 | 225.49 |
| 2025-12-16 | 225.49 |
| 2025-12-15 | 228.90 |
| 2025-12-12 | 222.09 |
| 2025-12-11 | 224.64 |
| 2025-12-10 | 222.94 |
| 2025-12-09 | 224.64 |
| 2025-12-08 | 220.39 |
| 2025-12-05 | 231.45 |
| 2025-12-04 | 233.15 |
| 2025-12-03 | 228.05 |
| 2025-12-02 | 223.79 |
| 2025-12-01 | 228.05 |
| 2025-11-28 | 236.56 |
| 2025-11-27 | 227.20 |
| 2025-11-26 | 230.60 |
| 2025-11-25 | 229.75 |
| 2025-11-24 | 230.60 |
| 2025-11-21 | 229.75 |
| 2025-11-20 | 222.09 |
| 2025-11-19 | 225.49 |
| 2025-11-18 | 229.75 |
| 2025-11-17 | 229.75 |
| 2025-11-14 | 229.75 |
| 2025-11-13 | 228.90 |
| 2025-11-12 | 229.75 |